Dashboard
Manage Tickers

CWKCushman & Wakefield plc

NYSE cushmanwakefield.com


$ 12.31 $ 0.21 (1.78 %)    

Friday, 02-Aug-2024 14:21:28 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 447.46 $ -4.38 (-0.97 %)
DIA $ 395.35 $ -3.40 (-0.85 %)
SPY $ 530.81 $ -6.48 (-1.21 %)
TLT $ 97.88 $ 0.25 (0.26 %)
GLD $ 224.84 $ -3.17 (-1.39 %)
$ 12.7
$ 12.10
$ 12.31 x 100
-- x --
$ 12.01 - $ 12.36
$ 6.24 - $ 13.79
2,509,504
na
2.94B
$ 1.60
$ 142.72
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-29-2024 06-30-2024 10-Q
2 04-29-2024 03-31-2024 10-Q
3 02-21-2024 12-31-2023 10-K
4 10-30-2023 09-30-2023 10-Q
5 07-31-2023 06-30-2023 10-Q
6 05-05-2023 03-31-2023 10-Q
7 02-24-2023 12-31-2022 10-K
8 11-04-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 05-05-2022 03-31-2022 10-Q
11 02-24-2022 12-31-2021 10-K
12 11-05-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-07-2021 03-31-2021 10-Q
15 02-26-2021 12-31-2020 10-K
16 11-06-2020 09-30-2020 10-Q
17 08-07-2020 06-30-2020 10-Q
18 05-08-2020 03-31-2020 10-Q
19 02-28-2020 12-31-2019 10-K
20 11-06-2019 09-30-2019 10-Q
21 08-02-2019 06-30-2019 10-Q
22 05-08-2019 03-31-2019 10-Q
23 02-28-2019 12-31-2018 10-K
24 11-14-2018 09-30-2018 10-Q
25 09-06-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jp-morgan-maintains-neutral-on-cushman--wakefield-raises-price-target-to-14
JP Morgan Maintains Neutral on Cushman & W...
07/30/2024 12:49:05

JP Morgan analyst Anthony Paolone maintains Cushman & Wakefield (NYSE:CWK) with a Neutral and raises the price target fr...

cushman--wakefield-q2-2024-adj-eps-020-beats-019-estimate-sales-2288b-miss-2373b-estimate
Cushman & Wakefield Q2 2024 Adj. EPS $0.20...
07/29/2024 20:12:21

Cushman & Wakefield (NYSE:CWK) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of ...

raymond-james-maintains-outperform-on-cushman--wakefield-raises-price-target-to-16
Raymond James Maintains Outperform on Cush...
07/25/2024 17:20:45

Raymond James analyst Patrick O'Shaughnessy maintains Cushman & Wakefield (NYSE:CWK) with a Outperform and raises th...

office-delinquencies-rise-as-working-from-home-and-higher-rates-factor-in
Office Delinquencies Rise As Working From ...
07/13/2024 14:24:16

The delinquency rate for U.S. office loans rose in June due to the work-from-home trend and high interest rates, with office lo...

jp-morgan-maintains-neutral-on-cushman--wakefield-raises-price-target-to-12
JP Morgan Maintains Neutral on Cushman & W...
06/21/2024 12:56:40

JP Morgan analyst Anthony Paolone maintains Cushman & Wakefield (NYSE:CWK) with a Neutral and raises the price target fr...

cushman--wakefield-plc-files-for-stock-shelf-offering-size-not-disclosed
Cushman & Wakefield Plc Files For Stock Sh...
05/20/2024 10:11:48

jefferies-initiates-coverage-on-cushman--wakefield-with-buy-rating-announces-price-target-of-13
Jefferies Initiates Coverage On Cushman & ...
04/10/2024 12:02:08

Jefferies analyst Peter Abramowitz initiates coverage on Cushman & Wakefield (NYSE:CWK) with a Buy rating and announces ...

wolfe-research-downgrades-cushman--wakefield-to-peer-perform
Wolfe Research Downgrades Cushman & Wakefi...
04/09/2024 10:53:29

Wolfe Research analyst Andrew Rosivach downgrades Cushman & Wakefield (NYSE:CWK) from Outperform to Peer Perform.

wolfe-research-downgrades-cushman--wakefield-to-peer-perform
Wolfe Research Downgrades Cushman & Wakefi...
04/08/2024 23:20:03

Wolfe Research analyst Andrew Rosivach downgrades Cushman & Wakefield (NYSE:CWK) from Outperform to Peer Perform.

cushman--wakefield-selected-by-mit-for-generative-ai-and-the-work-of-the-future-study
Cushman & Wakefield Selected By MIT For Ge...
04/05/2024 13:01:08

New initiative is convening leading companies and nonprofits with support from Google's Community Grants Fund

raymond-james-downgrades-cushman--wakefield-to-outperform-maintains-13-price-target
Raymond James Downgrades Cushman & Wakefie...
04/03/2024 18:02:09

Raymond James analyst Patrick O'Shaughnessy downgrades Cushman & Wakefield (NYSE:CWK) from Strong Buy to Outperform ...

recap-cushman--wakefield-q4-earnings
Recap: Cushman & Wakefield Q4 Earnings
02/20/2024 21:10:40

cushman--wakefield-q4-2023-adj-eps-045-beats-040-estimate-sales-255b-beat-243b-estimate
Cushman & Wakefield Q4 2023 Adj EPS $0.45 ...
02/20/2024 21:06:47

Cushman & Wakefield (NYSE:CWK) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of ...

earnings-scheduled-for-february-20-2024
Earnings Scheduled For February 20, 2024
02/20/2024 11:52:12

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue...

earnings-preview-for-cushman--wakefield
Earnings Preview For Cushman & Wakefield
02/19/2024 19:00:58

reliance-steel--aluminum-posts-upbeat-earnings-joins-jfrog-applovin-shake-shack-and-other-big-stocks-moving-higher-on-thursday
Reliance Steel & Aluminum Posts Upbeat Ear...
02/15/2024 15:23:41

U.S. stocks were mostly higher, with the Dow Jones index gaining more than 150 points on Wednesday.

analyst-expectations-for-cushman--wakefields-future
Analyst Expectations For Cushman & Wakefie...
01/25/2024 14:00:22

raymond-james-maintains-strong-buy-on-cushman--wakefield-raises-price-target-to-12
Raymond James Maintains Strong Buy on Cush...
01/25/2024 13:09:07

Raymond James analyst Patrick O'Shaughnessy maintains Cushman & Wakefield (NYSE:CWK) with a Strong Buy and raises th...

Core News & Articles
Cushman & Wakefield Says Working With Micr...
01/23/2024 22:06:56

5-analysts-have-this-to-say-about-cushman--wakefield
5 Analysts Have This to Say About Cushman ...
12/08/2023 17:00:44

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

08/02/2024 Humana Inc. (HUM)
08/05/2024 Marinus Pharmaceuticals, Inc. (MRNS)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)